Skip to main content
Clinical Trials/NL-OMON32278
NL-OMON32278
Withdrawn
Not Applicable

Identifying novel biomarkers in left ventricular hypertrophy patients - Biomarkers in left ventricular hypertrophy

Academisch Medisch Centrum0 sites200 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
biomarkers
Sponsor
Academisch Medisch Centrum
Enrollment
200
Status
Withdrawn
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients are included in this study when planned for surgical aortic valve replacement for severe aortic valve stenosis. Signs of left ventricular hypertrophy have to be present either on ECG, echocardiography or MRI. None of the exclusion criteria are met. Written informed consent is obtained.

Exclusion Criteria

  • Patients with concomitant heart disease: previous myocardial infarction, endocarditis. Patients younger than 18 years of age are also excluded from participation in this study. Patients who have a syndromic or genetic diagnosis, for example, Marfan\*s disease, trisomy 21, and Turner\*s syndrome

Outcomes

Primary Outcomes

Not specified

Similar Trials